Compare JRSH & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JRSH | HYFT |
|---|---|---|
| Founded | 2016 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.8M | 66.8M |
| IPO Year | 2017 | 2017 |
| Metric | JRSH | HYFT |
|---|---|---|
| Price | $5.68 | $1.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $4.00 | ★ $5.00 |
| AVG Volume (30 Days) | 74.7K | ★ 190.2K |
| Earning Date | 02-09-2026 | 03-12-2026 |
| Dividend Yield | ★ 5.68% | N/A |
| EPS Growth | ★ 485.71 | N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $166,263,870.00 | N/A |
| Revenue This Year | $11.64 | N/A |
| Revenue Next Year | $10.06 | $29.18 |
| P/E Ratio | $43.85 | ★ N/A |
| Revenue Growth | ★ 14.03 | N/A |
| 52 Week Low | $2.85 | $0.99 |
| 52 Week High | $5.81 | $3.00 |
| Indicator | JRSH | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 59.73 | 50.57 |
| Support Level | $4.37 | $1.21 |
| Resistance Level | $5.81 | $1.49 |
| Average True Range (ATR) | 0.21 | 0.10 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 86.21 | 63.52 |
Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.